BioNexus Gene Lab BGLC Cash Flow Statement (2018-2026)

NASDAQ BGLC
$1.45 +0.05 (+3.50%)
As of: Sep 9, 2026 · 3:50 PM EDT
Reported Financials

BioNexus Gene Lab Quarterly Cash Flow Statement

Periods 33 quarters
Latest Jun 2026

BioNexus Gene Lab reported cash from operations of -$0.42M and free cash flow of -$0.42M for the quarter ended Jun 2026, up 42.7% year over year. This cash flow statement covers 33 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.30M0.67M0.02M-0.14M-0.08M0.07M-0.07M-0.29M-2.61M0.35M-0.06M0.20M-1.35M-0.33M-0.62M-0.62M-0.71M-1.04M-0.54M-0.29M
Share-based CompensationStock Comp.
-0.09M0.79M
Deferred Taxes
0.00M0.02M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.00M97.000.00M0.00M0.76M0.04M0.18M0.06M0.20M0.07M
Non-cash ItemsNon-Cash Items
0.04M-0.06M0.00M-0.09M-0.05M-1.01M-0.79M-0.04M-0.34M-1.46M-0.51M
Cash from OperationsCash from Ops.
0.32M0.48M-0.04M-0.20M0.31M0.48M-0.12M-0.02M-0.90M-0.78M-0.04M-0.67M-1.60M0.22M-0.82M-0.74M-1.24M0.96M-0.15M-0.42M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
-0.33M-0.20M-0.11M-0.34M-0.02M-0.15M1.16M-0.11M0.12M-0.15M0.00M0.11M-0.48M0.53M-0.94M-0.24M0.55M
Change in InventoryChange Inventory
0.22M-0.03M0.13M-0.14M-0.42M0.97M-0.08M0.27M-0.06M-0.29M0.06M-0.17M0.36M-452.00-0.21M0.04M-0.21M-0.33M-0.01M
Change in Account PayablesChange Payables
0.05M-0.39M-0.21M-0.43M-0.13M0.65M-0.43M0.32M-0.25M-0.02M0.06M-0.51M0.20M0.46M-0.32M0.20M-1.11M-0.16M0.19M0.02M
Change in TaxesChange Taxes
-3.00
Other Working Capital ChangesOther WC Changes
Investing Activities
Capital ExpendituresCapex
410.000.00M0.03M0.00M0.00M0.47M0.01M0.03M0.25M0.02M0.17M-0.15M0.20M0.00M0.01M0.02M0.01M977.00325.00250.00
Sales of Property, Plant and EquipmentPP&E (Sale)
Divestments
0.01M0.01M0.01M0.02M0.08M0.01M0.01M0.20M0.57M0.01M
Change in Acquisitions & DivestmentsChange Acquisitions
-52.00-22.000.03M-708.000.21M0.09M0.20M0.57M
Cash from Investing ActivitiesCash from Investing
-0.06M-0.08M-0.20M-0.22M0.02M-0.05M-0.01M-0.00M-0.36M-1.43M0.00M0.06M-0.20M0.55M-0.02M-0.03M0.99M-0.01M-0.01M0.42M
Financing Activities
Other financing activitiesOther financing
0.00M0.00M
Cash from Financing ActivitiesCash from Financing
-0.01M-0.00M0.11M-0.00M-0.00M-0.00M-0.00M5.75M0.53M0.03M0.18M-0.06M-0.14M-860.00-0.00M0.03M0.27M0.06M0.01M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Additional items
Exchange Rate EffectFX Effect
-0.03M0.02M-0.04M-0.20M-0.20M0.23M-0.02M-0.19M-0.10M0.05M-0.07M-0.04M0.57M-0.41M0.04M0.22M0.03M-0.09M0.01M-0.01M
Change in Cash
0.22M0.42M-0.28M-0.50M1.45M-0.67M-0.15M-0.21M4.39M-1.63M-0.08M-0.48M-1.30M0.22M-0.80M-0.55M-0.18M1.13M-0.09M-0.01M
Free Cash FlowFCF
0.32M0.48M-0.07M-0.20M0.31M0.00M-0.13M-0.05M-1.15M-0.81M-0.21M-0.52M-1.80M0.22M-0.83M-0.76M-1.24M0.96M-0.15M-0.42M
Net Cash FlowNCF
0.25M0.40M-0.23M-0.31M0.33M0.42M-0.12M-0.03M4.49M-1.68M-0.01M-0.43M-1.86M0.63M-0.84M-0.77M-0.21M1.22M-0.10M0.01M